glp-1 agonsit New Guidelines for Type 2 Diabetes in 2025 What You Should Know Before
Description
The evidence for metabolic improvement with GLP-1 medications is substantial
doi: 10.1056/NEJMoa2206038.
Over 1.5 years, patients who took Zepbound lost ~21% of their body weight, and an incredible 83% of them lost more than 10% of their body weight
In addition, several patients have reported their loss of sexual desire (libido) while on GLP-1 agonists
According to research, modifying the gut microbiota can impact various physiological functions, including cognitive behavior and muscle performance [112]
What Clinical Trials Reveal About Tirzepatide and Mood The SURMOUNT-4 trial and other major studies tracking tirzepatide found that depression and anxiety each occurred in fewer than 2% of participants at treatment-ending doses
